PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
1-Year Return
3.82%
This Quarter Return
-2.96%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$151M
AUM Growth
-$35.4M
(-19%)
Cap. Flow
-$15.1M
Cap. Flow
% of AUM
-10.03%
Top 10 Holdings %
Top 10 Hldgs %
55.85%
Holding
113
New
18
Increased
21
Reduced
9
Closed
31
Top Buys
| 1 |
ICU Medical
ICUI
|
$5.47M |
| 2 |
Inspire Medical Systems
INSP
|
$5.04M |
| 3 |
SI-BONE Inc
SIBN
|
$4.49M |
| 4 |
Guardant Health
GH
|
$4.15M |
| 5 |
Standard BioTools
LAB
|
$3.91M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$8.12M |
| 2 |
Medtronic
MDT
|
$7.97M |
| 3 |
Azenta
AZTA
|
$5.7M |
| 4 |
Centene
CNC
|
$5.49M |
| 5 |
Zimmer Biomet
ZBH
|
$5.26M |
Sector Composition
| 1 | Healthcare | 93.33% |
| 2 | Industrials | 0.58% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exelixis
EXEL
$10.1B
| $1.69M | 0.34% |
+86,055
| New | +$1.69M |
|
|
VRAY
27
DELISTED
ViewRay, Inc.
VRAY
| $1.68M | 0.34% |
276,805
-344,034
| -55% | -$2.09M |
|
|
OTIC
28
DELISTED
Otonomy, Inc.
OTIC
| $1.66M | 0.33% |
896,387
+608,730
| +212% | +$1.13M |
|
29
Avanos Medical
AVNS
$579M
| $1.46M | 0.29% |
32,675
-7,885
| -19% | -$353K |
|
30
ProQR Therapeutics
PRQR
$237M
| $1.21M | 0.24% |
76,827
+20,024
| +35% | +$316K |
|
31
KALA BIO
KALA
$102M
| $1.06M | 0.21% |
+4,322
| New | +$1.06M |
|
|
PTLA
32
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $976K | 0.19% |
+50,000
| New | +$976K |
|
|
RDUS
33
DELISTED
Radius Health, Inc.
RDUS
| $942K | 0.19% |
+57,131
| New | +$942K |
|
34
Masimo
MASI
$8.08B
| $836K | 0.17% |
+7,783
| New | +$836K |
|
|
35
Boston Scientific
BSX
$160B
| $814K | 0.16% |
23,035
-229,890
| -91% | -$8.12M |
|
36
Rigel Pharmaceuticals
RIGL
$736M
| $764K | 0.15% |
33,206
+2,957
| +10% | +$68K |
|
37
Orthofix Medical
OFIX
$577M
| $669K | 0.13% |
12,738
-78,320
| -86% | -$4.11M |
|
|
ACET
38
DELISTED
Aceto Corp
ACET
| $591K | 0.12% |
704,034
+492,410
| +233% | +$413K |
|
39
Inogen
INGN
$224M
| $580K | 0.12% |
+4,669
| New | +$580K |
|
40
Verrica Pharmaceuticals
VRCA
$48.5M
| $521K | 0.1% |
6,392
+4,392
| +220% | +$358K |
|
41
Catalyst Pharmaceutical
CPRX
$2.46B
| $346K | 0.07% |
180,198
-22,291
| -11% | -$42.8K |
|
42
Carisma Therapeutics
CARM
$17.4M
| $284K | 0.06% |
+10,000
| New | +$284K |
|
|
RCM
43
DELISTED
R1 RCM Inc. Common Stock
RCM
| $281K | 0.06% |
35,283
-191,826
| -84% | -$1.53M |
|
|
CSII
44
DELISTED
Cardiovascular Systems, Inc.
CSII
| $227K | 0.05% |
+7,952
| New | +$227K |
|
|
ARQL
45
DELISTED
Arqule Inc
ARQL
| $199K | 0.04% |
+71,968
| New | +$199K |
|
46
Kodiak Sciences
KOD
$525M
| $173K | 0.03% |
+24,319
| New | +$173K |
|
|
GRCE
47
Grace Therapeutics, Inc. Common Stock
GRCE
$44.8M
| $157K | 0.03% |
+3,922
| New | +$157K |
|
48
ADMA Biologics
ADMA
$3.95B
| $89K | 0.02% |
37,170
-534,147
| -93% | -$1.28M |
|
|
SIEN
49
DELISTED
Sientra, Inc.
SIEN
| – | – |
0
| – | – |
|
50
Abbott
ABT
$230B
| – | – |
0
| – | – |
|